Journal of Neuroscience, Vol 10, 2400-2411, Copyright © 1990 by Society for Neuroscience
Proteolytic processing of beta-amyloid precursor by calpain I
R Siman, JP Card and LG Davis
Cephalon, Inc., West Chester, Pennsylvania 19380.
The beta-amyloid peptide is a core component of the neuritic plaques that
accumulate in Alzheimer's disease. Since the beta-peptide resides within a
family of precursor proteins (APPs), proteolytic processing of APP is
required for beta-amyloid deposition into plaques. Here, we have examined
the role played by the calcium-dependent cysteine protease calpain I in APP
processing. Immunoblotting with a specific APP antiserum was used to assess
the in vitro degradation of rat brain APP, which appears as a triplet of
polypeptides of Mr 110-130 kDa. Both soluble and membrane-bound APP were
extraordinarily sensitive to activated calpain I. APP contains at least 3
distinct calpain I cleavage sites. The most protease-sensitive site was
located within the highly acidic structural motif called the PEST domain, a
second site was upstream of the putative N-linked glycosylation sites, and
a third generated a 16 kDa carboxy-terminal fragment that contains the
beta- peptide. Based on light microscopic immunohistochemistry, APP and
calpain I were extensively colocalized within large numbers of neurons
distributed throughout the rat brain, with especially high levels of each
in neocortical layer 5, subiculum, globus pallidus, entopeduncular nucleus,
anterodorsal and reticular thalamic nuclei, motor trigeminal nucleus, deep
cerebellar nuclei, and Purkinje cells. Both antigens were most prevalent
within neuronal perikarya. Intraventricular kainate infusion, which is
known to cause rapid activation of hippocampal calpain I, produced a 32%
decline in APP levels after 24 hr, suggestive of in vivo degradation of APP
by calpain I. Following kainate-induced neuronal loss, both APP and calpain
I immunoreactivities appeared in the surrounding reactive astroglia. These
results indicate that calpain I may be involved in the normal and, perhaps,
pathological processing of APP, and that this processing could occur in
either neurons or reactive astrocytes. Calcium influx and calpain I
activation may provide a mechanism by which excitatory neurotransmission
regulates APP metabolism.